Librería: Chiron Media, Wallingford, Reino Unido
EUR 82,24
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardcover. Condición: New.
Idioma: Inglés
Publicado por Elsevier Science Health Science, 2017
ISBN 10: 0323532357 ISBN 13: 9780323532358
Librería: Revaluation Books, Exeter, Reino Unido
EUR 92,34
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 1st edition. 719 pages. 9.00x6.00x0.25 inches. In Stock.
Idioma: Inglés
Publicado por Elsevier - Health Sciences Division, 2017
ISBN 10: 0323532357 ISBN 13: 9780323532358
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 104,90
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 92,11
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Elsevier Health Sciences Aug 2017, 2017
ISBN 10: 0323532357 ISBN 13: 9780323532358
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 91,99
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more! Englisch.
Idioma: Inglés
Publicado por Elsevier Health Sciences, 2017
ISBN 10: 0323532357 ISBN 13: 9780323532358
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 102,38
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!